Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
27.24
+0.65 (2.44%)
At close: Mar 9, 2026, 4:00 PM EDT
26.00
-1.24 (-4.55%)
After-hours: Mar 9, 2026, 7:58 PM EDT
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $2.16 billion as of March 9, 2026. Its market cap has increased by 353.91% in one year.
Market Cap
2.16B
Enterprise Value
1.56B
1-Year Change
353.91%
Ranking
Category
Stock Price
$27.24
Market Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $2.16B, an increase of 244.98%. That is a compound annual growth rate of 49.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.10B | -26.73% |
| Dec 31, 2025 | 2.87B | 368.78% |
| Dec 31, 2024 | 612.65M | 73.31% |
| Dec 29, 2023 | 353.50M | -43.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocular Therapeutix | 2.24B |
| Day One Biopharmaceuticals | 2.19B |
| Zai Lab | 2.19B |
| Maze Therapeutics | 2.16B |
| Galapagos NV | 2.15B |
| Ascentage Pharma Group International | 2.13B |
| Iovance Biotherapeutics | 2.11B |
| Ultragenyx Pharmaceutical | 2.05B |